WOONSOCKET, R.I., Feb. 12, 2020 /PRNewswire/ -- CVS Health (NYSE:
CVS) today announced a series of leadership assignments to support
the company's continued focus on innovation and strategic
growth.
"We have set a clear and bold path for CVS Health to be the most
consumer-centric health company and transform the way care is
delivered, and we have laid a strong foundation for growth
following more than a year of successfully integrating the Aetna
business," said Larry J. Merlo,
President and CEO, CVS Health. "As we continue to innovate and
execute we will stay close to the markets we serve and respond to
the needs of our clients. The assignments announced today place our
leaders in areas where their unique experience and deep business
relationships will help us deliver on our core growth initiatives
and transformation strategies."
CVS Health leadership assignments include:
- Alan Lotvin, M.D., Executive
Vice President at CVS Health, has been appointed President of CVS
Caremark, and will also have oversight of CVS Specialty and CVS
Kidney Care. Lotvin has deep experience in the pharmacy benefit
management (PBM) business, with expertise in specialty pharmacy.
With the growing importance of specialty medicines and gene therapy
management, he is uniquely positioned to lead the company's next
wave of growth in this area. Lotvin previously led CVS Health's
transformation efforts.
- Jonathan Mayhew has been
appointed Executive Vice President, Transformation, and will be
responsible for the transformation product portfolio. Mayhew has
diverse health care experience, most recently serving as Senior
Vice President for the Aetna Markets organization. He has a
demonstrated track record of building and growing businesses to
serve needs in the marketplace and is uniquely positioned to bring
CVS Health's
transformation products to life across the company's open access
platform.
- Alec Cunningham has been
appointed Executive Vice President and Chief Operating Officer for
the Aetna business and will lead an expanded organization that will
focus on Medicare Advantage and government programs overall – an
area of growing importance. Cunningham joined CVS Health last year
from Concerto Healthcare, a leading provider organization that
serves dual-eligible, Medicare, Medicaid, and complex medical needs
patients.
- Derica Rice, Executive Vice
President and President, CVS Caremark, will depart CVS Health.
Derica will remain with the company through February to help ensure
a seamless transition.
"I want to thank Derica for his leadership during a period of
significant growth and evolution for our PBM business, and wish him
the best in his future endeavors," said Merlo. "I am confident we
are driving a sea change in how our key stakeholders think about
us, and how consumers partner with us to take control of their
health. These new assignments will accelerate that process."
About CVS Health
CVS Health employees are united around a common goal of becoming
the most consumer-centric health company in the world. We're
evolving based on changing consumer needs and meeting people where
they are, whether that's in the community at one of our nearly
10,000 local touchpoints, in the home, or in the palm of their
hand. Our newest offerings – from HealthHUB® locations that are
redefining what a pharmacy can be, to innovative programs that help
manage chronic conditions – are designed to create a
higher-quality, simpler and more affordable experience. Learn more
about how we're transforming health at
http://www.cvshealth.com.
Cautionary Statement Concerning Forward-Looking
Statements
The Private Securities Litigation Reform Act of 1995 provides a
safe harbor for forward-looking statements made by or on behalf of
CVS Health Corporation. Statements in this press release that are
forward-looking include our statements concerning the impact of
leadership assignments on our ability to deliver on our growth
initiatives and transformation strategies and our future responses
to the needs of our clients. By their nature, all forward-looking
statements involve risks and uncertainties. Actual results may
differ materially from those contemplated by the forward-looking
statements for a number of reasons as described in our Securities
and Exchange Commission ("SEC") filings, including those set forth
in the Risk Factors section and under the section entitled
"Cautionary Statement Concerning Forward-Looking Statements" in our
most recently filed Annual Report on Form 10-K and in our most
recently filed Quarterly Report on Form 10-Q.
You are cautioned not to place undue reliance on CVS Health's
forward-looking statements. These forward-looking statements are
and will be based upon management's then-current views and
assumptions regarding future events and operating performance, and
are applicable only as of the dates of such statements. CVS Health
does not assume any duty to update or revise forward-looking
statements, whether as a result of new information, future events
or otherwise, as of any future date.
Investor Contact:
Valerie
Haertel
CVS Health
401-770-4050
Valerie.Haertel@CVSHealth.com
Media Contact:
T.J. Crawford
CVS Health
212-457-0583
CrawfordT2@aetna.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cvs-health-announces-changes-to-support-innovation-and-growth-301003385.html
SOURCE CVS Health